Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

661 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Pathogenic mitochondrial DNA variants are associated with response to anti-VEGF therapy in ovarian cancer PDX models.
Boso D, Piga I, Trento C, Minuzzo S, Angi E, Iommarini L, Lazzarini E, Caporali L, Fiorini C, D'Angelo L, De Luise M, Kurelac I, Fassan M, Porcelli AM, Navaglia F, Billato I, Esposito G, Gasparre G, Romualdi C, Indraccolo S. Boso D, et al. Among authors: fassan m. J Exp Clin Cancer Res. 2024 Dec 19;43(1):325. doi: 10.1186/s13046-024-03239-w. J Exp Clin Cancer Res. 2024. PMID: 39702370 Free PMC article.
Coagulation factor X promotes resistance to androgen-deprivation therapy in prostate cancer.
Calì B, Troiani M, Bressan S, Attanasio G, Merler S, Moscarda V, Mosole S, Ricci E, Guo C, Yuan W, Gallagher L, Lundberg A, Bernett I, Figueiredo I, Arzola RA, Abreut EB, D'Ambrosio M, Bancaro N, Brina D, Zumerle S, Pasquini E, Maddalena M, Lai P, Colucci M, Pernigoni N, Rinaldi A, Minardi D, Morlacco A, Moro FD, Sabbadin M, Galuppini F, Fassan M, Rüschoff JH, Moch H, Rescigno P, Francini E, Saieva C, Modesti M, Theurillat JP, Gillessen S, Wilgenbus P, Graf C, Ruf W, de Bono J, Alimonti A. Calì B, et al. Among authors: fassan m. Cancer Cell. 2024 Oct 14;42(10):1676-1692.e11. doi: 10.1016/j.ccell.2024.08.018. Epub 2024 Sep 19. Cancer Cell. 2024. PMID: 39303726 Free article.
Development of two machine learning models to predict conversion from primary HER2-0 breast cancer to HER2-low metastases: a proof-of-concept study.
Miglietta F, Collesei A, Vernieri C, Giarratano T, Giorgi CA, Girardi F, Griguolo G, Cacciatore M, Botticelli A, Vingiani A, Fotia G, Piacentini F, Massa D, Zanghì F, Marino M, Pruneri G, Fassan M, Dei Tos AP, Dieci MV, Guarneri V. Miglietta F, et al. Among authors: fassan m. ESMO Open. 2024 Dec 19;10(1):104087. doi: 10.1016/j.esmoop.2024.104087. Online ahead of print. ESMO Open. 2024. PMID: 39705838 Free article.
Immune and gene-expression profiling in estrogen receptor low and negative early breast cancer.
Massa D, Vernieri C, Nicolè L, Criscitiello C, Boissière-Michot F, Guiu S, Bobrie A, Griguolo G, Miglietta F, Vingiani A, Lobefaro R, Taurelli Salimbeni B, Pinato C, Schiavi F, Brich S, Pescia C, Fusco N, Pruneri G, Fassan M, Curigliano G, Guarneri V, Jacot W, Dieci MV. Massa D, et al. Among authors: fassan m. J Natl Cancer Inst. 2024 Dec 1;116(12):1914-1927. doi: 10.1093/jnci/djae178. J Natl Cancer Inst. 2024. PMID: 39083015 Free PMC article.
Crosstalk between MicroRNAs and Oxidative Stress in Coeliac Disease.
Pelizzaro F, Cardin R, Sarasini G, Minotto M, Carlotto C, Fassan M, Palo M, Farinati F, Zingone F. Pelizzaro F, et al. Among authors: fassan m. Inflamm Intest Dis. 2024 Jan 24;9(1):11-21. doi: 10.1159/000536107. eCollection 2024 Jan-Dec. Inflamm Intest Dis. 2024. PMID: 38298886 Free PMC article. Review.
Profile of matrix-entrapped extracellular vesicles of microenvironmental and infiltrating cell origin in decellularized colorectal cancer and adjacent mucosa.
Tassinari S, D'Angelo E, Caicci F, Grange C, Burrello J, Fassan M, Brossa A, Bao RQ, Spolverato G, Agostini M, Collino F, Bussolati B. Tassinari S, et al. Among authors: fassan m. J Extracell Biol. 2024 Feb 26;3(3):e144. doi: 10.1002/jex2.144. eCollection 2024 Mar. J Extracell Biol. 2024. PMID: 38939413 Free PMC article.
Innate Immunity Activation in Newly Diagnosed Ileocolonic Crohn's Disease: A Cohort Study.
Angriman I, Bordignon G, Kotsafti A, Mescoli C, Scarpa M, Ruffolo C, Fassan M, Dei Tos AP, D'Incà R, Savarino EV, Zingone F, Pucciarelli S, Bardini R, Castagliuolo I, Scarpa M. Angriman I, et al. Among authors: fassan m. Dis Colon Rectum. 2024 May 1;67(5):681-692. doi: 10.1097/DCR.0000000000003145. Epub 2024 Feb 6. Dis Colon Rectum. 2024. PMID: 38319717
Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial.
Randon G, Lonardi S, Fassan M, Palermo F, Tamberi S, Giommoni E, Ceccon C, Di Donato S, Fornaro L, Brunetti O, De Vita F, Bittoni A, Chini C, Spallanzani A, Nappo F, Bethaz V, Strippoli A, Latiano T, Cardellino GG, Giuliani F, Morano F, Niger M, Raimondi A, Prisciandaro M, Pircher CC, Sciortino C, Marchesi S, Garattini SK, Airò G, Miceli R, Di Bartolomeo M, Pietrantonio F. Randon G, et al. Among authors: fassan m. Lancet Oncol. 2024 Dec;25(12):1539-1550. doi: 10.1016/S1470-2045(24)00580-1. Epub 2024 Nov 15. Lancet Oncol. 2024. PMID: 39557058 Clinical Trial.
IMMUNOREACT 9 metachronous rectal cancers have high HLA-ABC expression on healthy epithelium but a lower infiltration of CD3+ T cells than primary lesions.
Salmaso B, Scarpa M, Pellegrini V, Stepanyan A, Salmaso R, Kotsafti A, Scognamiglio F, Gregori D, Rivella G, De Simoni O, Becherucci G, Negro S, Vignotto C, Spolverato G, Ruffolo C, Angriman I, Bergamo F, Chiminazzo V, Maretto I, Zizzo M, Marchegiani F, Facci L, Brignola S, Businello G, Licia L, Guzzardo V, Dal Santo L, Carlotta C, Massani M, Pozza A, Cataldo I, Stecca T, Dei Tos AP, Zagonel V, Pilati P, Franzato B, Scapinello A, Pozza G, Godina M, Pirozzolo G, Recordare A, Mondi I, Lio CD, Merenda R, Bordignon G, Verdi D, Saadeh L, Guerriero S, Piccioli A, Noaro G, Cola R, Portale G, Cipollari C, Zuin M, Candioli S, Gavagna L, Ricagna F, Ortenzi M, Guerrieri M, Tagliente G, Tomassi M, Tedeschi U, Porzionato A, Agostini M, Bao RQ, Cavallin F, Tussardi G, Di Camillo B, Bardini R, Castagliuolo I, Pucciarelli S, Fassan M, Scarpa M. Salmaso B, et al. Among authors: fassan m. Sci Rep. 2024 Nov 30;14(1):29821. doi: 10.1038/s41598-024-80299-0. Sci Rep. 2024. PMID: 39616209 Free PMC article.
Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO.
Raimondi A, Lonardi S, Murgioni S, Cardellino GG, Tamberi S, Strippoli A, Palermo F, De Manzoni G, Bencivenga M, Bittoni A, Chiodoni C, Lorenzini D, Todoerti K, Manca P, Sangaletti S, Prisciandaro M, Randon G, Nichetti F, Bergamo F, Brich S, Belfiore A, Bertolotti A, Stetco D, Guidi A, Torelli T, Vingiani A, Joshi RP, Khoshdeli M, Beaubier N, Stumpe MC, Nappo F, Leone AG, Pircher CC, Leoncini G, Sabella G, Farulla LA, Alessi A, Morano F, Martinetti A, Niger M, Fassan M, Di Maio M, Kaneva K, Milione M, Nimeiri H, Sposito C, Agnelli L, Mazzaferro V, Di Bartolomeo M, Pietrantonio F. Raimondi A, et al. Among authors: fassan m. Ann Oncol. 2024 Dec 3:S0923-7534(24)04953-6. doi: 10.1016/j.annonc.2024.11.016. Online ahead of print. Ann Oncol. 2024. PMID: 39637944 Free article.
661 results